Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03557918 |
Title | Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Matthew Galsky |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Georgetown University | Washington | District of Columbia | 20057 | United States | Details | |
Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | United States | Details | |
University of Kansas Medical Center Research Institute, Inc. | Westwood | Kansas | 66205 | United States | Details | |
Dana Farber- Partners Cancer Care, Inc | Boston | Massachusetts | 02215 | United States | Details | |
Ichan School of Medicine at Mount Sinai | New York | New York | 10029-6542 | United States | Details | |
University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | United States | Details | |
Huntsman Cancer Institute University of Utah | Salt Lake City | Utah | 84112 | United States | Details |